During the past decade, China Meitan General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "China Meitan General Hospital" #1 sponsor was "China Meitan General Hospital" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Chipscreen Biosciences, Ltd." with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "University of Oxford" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "China Meitan General Hospital" #1 collaborator was "Marino Biotechnology Co., Ltd." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "China Meitan General Hospital" are "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease, Hypercholesterolemia, Hypertension" (1 trials), "Coronary Heart Disease" (1 trials), "Impaired Glucose Tolerance" (1 trials) and "Mesothelin Positive Tumors" (1 trials). Many other conditions were trialed in "China Meitan General Hospital" in a lesser frequency.

Most popular intervention types in "China Meitan General Hospital" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acarbose" (1 trials), "Chiglitazar" (1 trials), "Matching Placebo" (1 trials), "No Treatment" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "China Meitan General Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "China Meitan General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in China Meitan General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in China Meitan General Hospital, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".